Blocking the CGRP Receptor: Differences across Human Vascular Beds
Multiple drugs targeting the calcitonin gene-related peptide (CGRP) receptor have been developed for the treatment of migraine. Here, the effect of the small-molecule CGRP receptor antagonist zavegepant (0.1 nM-1 µM) on CGRP-induced relaxation in isolated human coronary arteries (HCAs) was investiga...
Saved in:
Main Authors: | Tessa de Vries (Author), Deirdre M. Boucherie (Author), Antoon van den Bogaerdt (Author), A. H. Jan Danser (Author), Antoinette MaassenVanDenBrink (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Functional Analysis of TRPA1, TRPM3, and TRPV1 Channels in Human Dermal Arteries and Their Role in Vascular Modulation
by: Eduardo Rivera-Mancilla, et al.
Published: (2024) -
Pharmacological Nature of the Purinergic P2Y Receptor Subtypes That Participate in the Blood Pressure Changes Produced by ADPβS in Rats
by: Roberto C. Silva-Velasco, et al.
Published: (2023) -
Monoclonal antibodies blocking CGRP for prevention of migraine
by: Alicja Maziarczyk, et al.
Published: (2023) -
Pharmacological Profile of the Purinergic P2Y Receptors That Modulate, in Response to ADPβS, the Vasodepressor Sensory CGRPergic Outflow in Pithed Rats
by: Alejandro D. Miguel-Martínez, et al.
Published: (2023) -
The PLGA nanoparticles for sustainable release of CGRP to ameliorate the inflammatory and vascular disorders in the lung of CGRP-deficient rats
by: Fang Wang, et al.
Published: (2021)